Skip to main content

Peer Review reports

From: Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma

Original Submission
9 Nov 2022 Submitted Original manuscript
9 Dec 2022 Reviewed Reviewer Report
3 Jan 2023 Reviewed Reviewer Report
8 Jan 2023 Author responded Author comments - Yunsheng Xu
9 Jan 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 2
8 Jan 2023 Submitted Manuscript version 2
11 Jan 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 3
11 Jan 2023 Submitted Manuscript version 3
13 Jan 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 4
13 Jan 2023 Submitted Manuscript version 4
19 Jan 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 5
19 Jan 2023 Submitted Manuscript version 5
19 Jan 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 6
19 Jan 2023 Submitted Manuscript version 6
24 Jan 2023 Reviewed Reviewer Report
2 Feb 2023 Reviewed Reviewer Report
6 Feb 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 7
6 Feb 2023 Submitted Manuscript version 7
7 Feb 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 8
7 Feb 2023 Submitted Manuscript version 8
7 Feb 2023 Author responded Author comments - Yunsheng Xu
Resubmission - Version 9
7 Feb 2023 Submitted Manuscript version 9
Publishing
9 Feb 2023 Editorially accepted
31 Mar 2023 Article published 10.1186/s12885-023-10625-8

You can find further information about peer review here.

Back to article page